Introduction {#sec1_1}
============

Plum is a stone fruit tree belonging to the genus *Prunus* and subgenus *Prunus*. Findings of recent studies have shown that dried plum, prune (*Prunus domestica* L.), can be effective in both preventing and reversing bone loss \[[@B1],[@B2],[@B3]\].

The effects of dried plum on bone loss protection \[[@B2],[@B3]\] and even its reversion were reported in two separate osteopenia models \[[@B4],[@B5]\]. Following plum treatment in ovariectomized female rats, bone mineral density (BMD) loss of the femur and lumbar vertebrae were prevented and serum insulin-like growth factor-I (IGF-I) increased \[[@B4],[@B6]\]. The elevation of IGF-I was accompanied by an enhanced level of osteogenesis; therefore, plum can improve bone formation. Some studies reported that plum inhibited bone resorption significantly \[[@B7]\]. In a study conducted on animal models, plum impeded BMD loss of the 4th lumbar vertebra and femurs in orchidectomized rats \[[@B3]\]. The findings of a short-term clinical trial indicated that the consumption of dried plum (100 g/day) by postmenopausal women significantly improved the levels of bone formation indices including serum, total alkaline phosphatase and bone-specific alkaline phosphatase activities, and also IGF-I \[[@B8]\]. Several studies \[[@B1],[@B2],[@B3],[@B4],[@B5]\] have shown that plum can improve bone formation potential in adults but we did not find any published studies designed to investigate the effects of plum extract on cartilage and bone histogenesis under normal conditions, particularly during the embryonic period. We hypothesized that plum extract can improve chondrogenesis and osteogenesis. Since maternal nutrition is an effective factor in pregnancy, the present study was designed to investigate the effects of feeding with plum extracts on the chondrogenic and osteogenic potential of an embryonic and neonatal mouse model.

Methods and Materials {#sec1_2}
=====================

Extract Preparation {#sec2_1}
-------------------

*P. domestica* L. fruits were collected from Sepidan, a city located in Fars Province, Iran. A total of 150 g dried plum was extracted from 1,000 g fresh plum. Hydroalcoholic extract was prepared using a percolation method and pureed with a desiccator. Also fruit juice from 1,000 g fresh plum was condensed to 400 ml in a 60°C water bath.

Animals and Extract Administrations {#sec2_2}
-----------------------------------

Thirty-two female mice weighing between 30 and 40 g obtained from the Animal House, Shiraz University of Medical Sciences, Shiraz, Iran were used for the study. The animals were adapted to the laboratory conditions for 2 weeks prior to the beginning of the experiments. Mice were kept at a controlled room temperature of 22--24°C with a light:dark cycle of 12:12 h (lights on at 09.00 h and off at 21.00 h). The mice had free access to food and tap water. The animal experiments were approved by the Institutional Animal Ethics and Health Committee, Biology Department, Shiraz University. Female mice were caged with male mice and insemination was verified the following morning by checking for the presence of a copulation plug in the vagina. The day the vaginal plug was observed was designated as day 0 of pregnancy (gestation day 0, GD 0). Pregnant mice were weighed on the following GDs: 5, 8, 12 and 15. A sketchmatic representation of the experimental procedure is given in figure [1](#F1){ref-type="fig"}.

Pregnant mice were divided into two experimental and two control groups (n = 8). Mice of the first experimental group were given 1.6 g/kg plum hydroalcoholic extract (PHE) orally from GD 1 to 18. Mice of the second experimental group were treated with the same dose for the entire gestational period as well as 10 days postpartum.

For comparison of nonpregnant and pregnant mice, nonpregnant female mice weighing between 30 and 40 g were divided into experimental and control groups (n = 10) treated with PHE (1.6 g/kg). Also the nonpregnant mice (n = 10) were treated with plum juice extract (PJE, 8 ml/kg) to compare the effects of these extracts. The extracts were suspended in 0.2 ml distilled water and administered to experimental groups orally by needle gavage for 30 days. The control groups received 0.2 ml distilled water under similar conditions to other groups. Mice were weighed weekly.

Osteogenesis Index Measurement {#sec2_3}
------------------------------

Fetuses of the PHE group at GD 19 and newborns at the 10th day postpartum were sacrificed under deep anesthesia. Their crown-rump length and weight were measured. Sixty-one fetuses and 40 newborns were fixed in ethanol 95s%, and then they were skinned and eviscerated. They were defatted in acetone for 3 days at 37°C and stained with a mixture of Alcian blue (Merck, Darmstadt, Germany) and alizarin red S (Riedel-de Haën, Germany). The animals were cleared in a series of decreasing concentrations of potassium hydroxide in glycerin and then kept in glycerin. The cartilaginous skeleton was stained with blue dye, and the ossified skeleton with red. The total length of the femur and tibia and the length of their ossified zones were measured under a stereomicroscope equipped with a ruled eyepiece (Zeiss, Mc-80; Jena, Germany). The osteogenesis index was calculated by dividing the ossified length by the total length of each bone (fig. [2](#F2){ref-type="fig"}).

Calcium Content Measurement {#sec2_4}
---------------------------

At the end of the experiment, the pregnant and nonpregnant mice were sacrificed under deep anesthesia and their thighs were dissected out. Then the femurs were removed and cleaned. Bones were dried for 24 h in a 56°C incubator. The dried bones were ashed at 550°C for 20 h in an oven (model 10500, Thermolyne, Dubuque, Iowa, USA). The bone was powdered, and 0.03 g of the powder was dissolved in 250 μl HCl; this solution was then diluted with 31 ml distilled water. Standard solutions were prepared to contain 0.2 g CaCl~2~ in 2s% HCl (density 720 ppm). Stock solutions were diluted to 0.03 ppm. Calcium (Ca) content was measured using a flame photometer (model 8515, Jenway, Stone, Staffs, UK). The linear fit equation was calculated with Microsoft Excel (Microsoft Corp., Redmond, Wash., USA) as y = 0.0073x s+ 0.0624 where y is the bone Ca content and x is the Ca content of the standard solution.

Serum Contents Assay {#sec2_5}
--------------------

At the end of the experiment, the blood samples of pregnant and nonpregnant mice were taken by heart puncture, then their serum portions were separated after they were centrifuged for 15 min at 2,000 rpm. Then Ca, magnesium, phosphorus (P) and alkaline phosphatase, blood glucose, triglyceride, cholesterol, high- and low-density lipoprotein concentrations of serum were measured using automated clinical analyzer (Biolis 24i, Japan) at the Biochemistry Center of the Research Center of Nemazee Hospital, Shiraz.

Statistical Analysis {#sec2_6}
--------------------

Results are presented as means and standard deviations. Data were analyzed by ANOVA. Tukey\'s and Scheffé\'s tests and the least significant difference method as post hoc tests were also performed. A significance level of 0.05 was set for all statistical analyses.

Results {#sec1_3}
=======

The yield (w/w) of dried plum extract was 7.95s% (g/g) and that of PJE was 40s% (g/g).

There were no statistically significant differences (p = 0.92) in the body weight of pregnant mice (51.00 ± 5.68 g) compared to the control group (52.68 ± 6.27 g). The weight of breast-feeding mice (37.25 ± 4.17 g) did not show a significant difference (p = 0.62) compared to their control group (39.33 ± 4.30 g). The body weight of nonpregnant mice in the PHE-treated group (31.02 ± 2.82 g) and of PJE-treated mice (27.88 ± 1.55 g) did not show any significant difference compared to their control groups (p = 0.09 and p = 0.87, respectively).

Fetuses of mice treated with PHE weighed significantly (1.41 ± 0.12 g) more than those of the control group (1.37 ± 0.12 g, p = 0.004), and crown-rump length of the newborn mice (4.61 ± 0.25 mm) was longer than that of the control group (4.48 ± 0.31 mm, p = 0.001).

The Alcian blue/alizarin red S staining technique indicated that total femur length and femur ossified length were longer in fetuses of the PHE-treated group (p = 0.005 and 0.014, respectively), whereas tibia length was not significantly different as compared to the control group (table [1](#T1){ref-type="table"}). Both the femur and tibia ossified lengths in newborns of PHE-treated mice were higher than those of their control groups (p = 0.000 and 0.002, respectively, table [1](#T1){ref-type="table"}). However, only the femur osteogenesis index of newborns was significantly higher (p = 0.007) in comparison to the control groups (table [1](#T1){ref-type="table"}).

There were no statistically significant differences in the Ca content of bone in pregnant mice and mice that fed their pups, compared to their controls (table [2](#T2){ref-type="table"}). However, the Ca content of bone in nonpregnant mice was significantly higher in the PHE (p = 0.049) and PJE groups (p = 0.020) than in the control groups (table [2](#T2){ref-type="table"}).

Daily dietary supplementation with PHE did not significantly change the levels of serum Ca, alkaline phosphatase, P, magnesium in pregnant and breast-feeding mice, compared to control groups (table [2](#T2){ref-type="table"}). The amount of Ca in PJE-treated groups was significantly higher than that in the control group (p = 0.036) whereas high concentrations of Ca in the PHE-treated group were not significant compared to the control group (table [2](#T2){ref-type="table"}). The concentration of P was significantly higher in PHE-treated mice (p = 0.028); however, the higher concentration of P in PJE-treated mice compared to the control mice was not statistically significant (table [2](#T2){ref-type="table"}). Daily dietary supplementation with PHE did not significantly change the levels of serum glucose, triglyceride, cholesterol, high-density and low-density lipoprotein in pregnant and breast-feeding mice compared to control groups (table [3](#T3){ref-type="table"}). Triglyceride and cholesterol concentrations of serum in PJE-treated mice (p = 0.001 and 0.029, respectively) were significantly higher than in the control group (table [3](#T3){ref-type="table"}).

Discussion {#sec1_4}
==========

According to our data, the femur length of fetuses and newborns in the PHE-treated group, the crown-rump length of newborns in the PHE-treated group, and the bone and serum Ca and P contents of nonpregnant mice in the PJE-treated group were significantly increased when compared with those of controls. Despite the greater lengths of femur and tibia in fetuses and newborns of plum extract-treated animals, the Ca contents of bone and serum of their mothers did not change as compared to the control mice. These data confirmed the effects of plum on bone in both mature and immature animals as previously reported \[[@B3],[@B4],[@B5],[@B6]\].

It has been reported that nutrient supplements such as soy isoflavones, Ca and vitamin D had limited ability to restore bone mass and its structure \[[@B9],[@B10]\], but the bone-protective potential increased significantly in MC3T3--1 (osteoblast-like cells) treated with dried plum extract \[[@B4]\]. This could be due to relatively high amounts of polyphenols (441 mg/l) in plum juice \[[@B11]\] and plum ethanol extract \[[@B12]\]. Phenolic compounds such as isoflavones and lignans positively influence bone health \[[@B2],[@B13],[@B14],[@B15]\] and inhibit bone resorption due to their antioxidant and anti-inflammatory properties \[[@B7],[@B16]\]. Polyphenols also directly stimulate osteoblasts and favorably alter bone formation markers, which would suggest the possibility of anabolic properties \[[@B17],[@B18]\]. Rutin, one of the polyphenols of plum juice \[[@B11]\], increased the serum osteocalcin and BMD of estrogen-deficient osteopenic rats \[[@B17]\]. BMD of fetuses treated with isoflavones was increased significantly \[[@B19]\].

Dried plum, plum extract and plum juice are rich in phenolic compounds such as neochlorogenic and chlorogenic acids, which act as antioxidants \[[@B11],[@B12],[@B20],[@B21]\]. Antioxidants have been shown to inhibit bone resorption and stimulate bone formation \[[@B22],[@B23]\].

The pH buffering capacity of potassium enhanced bone health and decreased bone resorption \[[@B24],[@B25]\]. Potassium also increased bone formation markers such as serum IGF-I in postmenopausal women \[[@B25]\]. A third component of plum known to play a role in bone metabolism is vitamin K \[[@B11],[@B12]\]. Vitamin K facilitates the carboxylation of proteins such as osteocalcin and consequently is involved in bone matrix synthesis \[[@B26]\]. Vitamin K increases serum osteocalcin and lumbar bone mass in children that were treated with long-term glucocorticoid \[[@B27]\]. Vitamin K directly stimulates osteoblast differentiation and inhibits osteoclastogenesis in vitro \[[@B26]\]. Although supplemental potassium, vitamin K and individual polyphenols such as rutin positively influence bone metabolism, there are no reports to show the effects of these components together, as in plum components, on bone. Ovariectomized female rats treated with 5 or 25s% dried plum did not show bone loss induced by gonadal hormone deficiency of femur, vertebral column and reduction in whole-body BMD. Increased level of IGF-I in rats treated with dried plum and its extract enhanced trabecular bone volume \[[@B6],[@B28],[@B29]\]. The tibial osteogenesis index in fetuses and newborns did not reveal significant differences compared to the control mice. This may be due to its developmental stage and ossification center formation, which is later in the tibia than in the femur.

According to our data, the other serum components such as alkaline phosphatase were not altered in plum extract-treated mice as compared to the control groups. There were not any alterations in the alkaline phosphatase levels in rats following a 90-day period of vitamin K administration \[[@B5]\] and dried plum treatment \[[@B6]\]. Therefore, plum extract did not appear to alter bone mineralization, however, it influenced osteoblast number and had optimal effects on bone metabolism based on both bone resorption and formation \[[@B3]\]. Higher concentrations of Ca and P in PJE- and PHE-treated mice, respectively, may be due to the different components of these extracts.

Conclusion {#sec1_5}
==========

The findings showed that plum extract increased femoral and tibial lengths, bone and serum Ca contents of adult nonpregnant animals and osteogenesis indices of fetuses and newborns of pregnant mice. Further investigation is needed to clarify the exact influence of plum on bone metabolism and its potential mechanism.
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![Sketchmatic representation of the experimental procedure.](mpp-0022-0351-g01){#F1}

![Effects of plum extracts on cleared newborn skeleton stained with alizarin red S and Alcian blue. The cartilaginous and bony parts of the skeleton stained blue and red, respectively. Mice treated with PHE (left) were longer than control mice (right).](mpp-0022-0351-g02){#F2}

###### 

Effects of PHE on tibial and femoral lengths (mm) and osteogenesis index of 19th GD fetuses and 10-day-old newborn mice in different groups

  Groups                    Femoral length                                Tibial length   Femoral ossified length                       Tibial ossified length                        Femoral osteogenesis index                    Tibial osteogenesis index
  ---------- -------------- --------------------------------------------- --------------- --------------------------------------------- --------------------------------------------- --------------------------------------------- ---------------------------
  Fetuses    PHE (n = 31)   3.55 ± 0.21[\*](#T1F1){ref-type="table-fn"}   3.89 ± 0.15     2.27 ± 0.14[\*](#T1F1){ref-type="table-fn"}   2.61 ± 0.24                                   0.64 ± 0.04                                   0.67 ± 0.06
             CON (n = 30)   3.42 ± 0.26                                   3.82 ± 0.18     2.16 ± 0.19                                   2.54 ± 0.20                                   0.63 ± 0.04                                   0.66 ± 0.05
                                                                                                                                                                                                                                    
  Newborns   PHE (n = 20)   7.13 ± 0.71[\*](#T1F1){ref-type="table-fn"}   9.50 ± 0.52     6.18 ± 0.74[\*](#T1F1){ref-type="table-fn"}   8.19 ± 0.80[\*](#T1F1){ref-type="table-fn"}   0.87 ± 0.09[\*](#T1F1){ref-type="table-fn"}   0.87 ± 0.07
             CON (n = 20)   6.57 ± 0.45                                   8.49 ± 0.72     5.29 ± 0.50                                   7.43 ± 0.85                                   0.81 ± 0.06                                   0.87 ± 0.05

CON = Control.

Mean values were significantly different from those of the control group:

p \< 0.05.

Femoral length of PHE fetuses compared to CON: p = 0.005; femoral length of PHE newborns compared to CON: p = 0.000; femoral ossified length of PHE fetuses compared to CON: p = 0.014; femoral ossified length of PHE newborns compared to CON: p = 0.000; tibial ossified length of PHE newborns compared to CON: p = 0.002; femoral osteogenesis index of PHE newborns compared to their CON: p = 0.007.

###### 

Effect of PHE on blood contents of Ca, magnesium (Mg), P, alkaline phosphatase (ALP) and Ca content of bone of mice in different groups

  Groups                               Ca mg/dl                                       ALP U/l          P mg/dl                                       Mg mg/dl      Ca content of bone mg/g dry weight
  --------------------- -------------- ---------------------------------------------- ---------------- --------------------------------------------- ------------- -------------------------------------------------
  Pregnant mice         PHE (n = 8)    9.7 ± 0.50                                     164.00 ± 43.59   7.59 ± 4.13                                   2.44 ± 0.24   0.0645 ± 0.0003
                        CON (n = 8)    9.5 ± 0.51                                     152.40 ± 52.09   6.48 ± 2.10                                   2.36 ± 0.13   0.0651 ± 0.0004
                                                                                                                                                                   
  Breast-feeding mice   PHE (n = 8)    9.63 ± 0.17                                    211.50 ± 42.35   6.20 ± 1.36                                   2.83 ± 0.19   0.0654 ± 0.0003
                        CON (n = 8)    9.46 ± 0.40                                    156.20 ± 31.93   7.08 ± 2.19                                   3.02 ± 0.41   0.0650 ± 0.0003
                                                                                                                                                                   
  Nonpregnant mice      PHE (n = 10)   9.98 ± 0.42                                    166.12 ± 22.22   9.10 ± 3.28[\*](#T2F1){ref-type="table-fn"}   3.10 ± 0.75   0.0652 ± 0.0005[\*](#T2F1){ref-type="table-fn"}
                        PJE (n = 10)   10.14 ± 0.40[\*](#T2F1){ref-type="table-fn"}   220.75 ± 87.71   7.16 ± 1.54                                   2.98 ± 0.84   0.0651 ± 0.0003[\*](#T2F1){ref-type="table-fn"}
                        CON (n = 10)   9.74 ± 0.44                                    199.88 ± 97.97   6.37 ± 1.93                                   2.59 ± 0.27   0.0648 ± 0.0003

CON = Control. Mean values were significantly different from those of the control group:

p \< 0.05

Ca of PJE compared to CON nonpregnant mice: p = 0.036; P of PHE compared to CON nonpregnant mice: p = 0.028; Ca content of bone of PHE compared to CON nonpregnant mice: p = 0.049; Ca content of bone of PJE compared to CON nonpregnant mice: p = 0.020.

###### 

Effect of PHE on blood concentration of glucose, triglyceride, cholesterol, high- and low-density lipoproteins (HDL and LDL) of mice in different groups

  Groups                               Glucose mg/dl    Triglyceride mg/dl                              Cholesterol mg/dl                                HDL mg/dl       LDL mg/dl
  --------------------- -------------- ---------------- ----------------------------------------------- ------------------------------------------------ --------------- ---------------
  Pregnant mice         PHE (n = 8)    146.57 ± 23.96   88.29 ± 15.50                                   77.57 ± 9.03                                     39.57 ± 7.04    20.34 ± 8.00
                        CON (n = 8)    164.20 ± 33.95   73.6 ± 3.97                                     75.80 ± 22.91                                    37.00 ± 11.90   24.08 ± 11.23
  Breast-feeding mice   PHE (n = 8)    152.00 ± 19.08   52.25 ± 0.96                                    118.50 ± 4.04                                    69.25 ± 4.27    38.80 ± 3.73
                        CON (n = 8)    138.40 ± 42.30   67.80 ± 12.81                                   120.40 ± 21.20                                   66.60 ± 12.92   40.24 ± 13.39
  Nonpregnant mice      PHE (n = 10)   166.38 ± 37.36   63.38 ± 10.51                                   93.63 ± 18.49                                    51.57 ± 18.09   29.20 ± 8.65
                        PJE (n = 10)   173.50 ± 22.15   89.88 ± 22.89[\*](#T3F1){ref-type="table-fn"}   105.88 ± 16.54[\*](#T3F1){ref-type="table-fn"}   56.38 ± 10.80   31.53 ± 9.26
                        CON (n = 10)   167.47 ± 19.94   66.88 ± 9.82                                    90.65 ± 13.44                                    51.71 ± 10.22   25.56 ± 9.66

CON = Control. Mean values were significantly different from those of the control group:

p \< 0.05.

Triglyceride concentration of PJE nonpregnant mice compared to CON: p = 0.001; cholesterol concentration of PJE nonpregnant mice compared to CON: p = 0.029.
